Virax Biolabs Group Limited

NasdaqCM:VRAX Stock Report

Market Cap: US$10.5m

Virax Biolabs Group Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of VRAX?
Owner TypeNumber of SharesOwnership Percentage
Institutions71,3191.64%
Individual Insiders287,9876.63%
General Public3,982,65091.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 142.7%.


Top Shareholders

Top 9 shareholders own 8.28% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
6.63%
James Foster
287,987US$694.0k0%no data
0.65%
Virtu Financial LLC, Asset Management Arm
28,058US$67.6k0%no data
0.59%
Hudson River Trading LLC, Asset Management Arm
25,672US$61.9k0%no data
0.25%
Renaissance Technologies LLC
11,001US$26.5k0%no data
0.13%
UBS Asset Management AG
5,601US$13.5k118%no data
0.012%
Geode Capital Management, LLC
542US$1.3k0%no data
0.0069%
Qube Research & Technologies Ltd
300US$723.10%no data
0.0023%
Wells Fargo & Company, Securities and Brokerage Investments
100US$240.70%no data
0.001%
Headlands Technologies Llc, Asset Management Arm
45US$108.80%no data